600873 梅花生物
按盤價 
10.000 +0.030 (+0.301%) | 2026/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 5,985,632 | -4.51% | 24,208,675 | 25,069,288 | 27,760,612 | 27,937,153 | |
| 減：營業總成本 | 5,882,482 | 12.80% | 21,603,821 | 21,862,600 | 24,158,623 | 22,990,081 | |
| 其中:營業成本 | 5,415,277 | 14.57% | 19,609,399 | 20,036,699 | 22,297,122 | 20,915,784 | |
| 財務費用 | 25,546 | -221.48% | 4,005 | (117,264) | (33,427) | 83,877 | |
| 資產減值損失 | 66 | -136.52% | (36,035) | (6,982) | (5,415) | (5,958) | |
| 公允價值變動收益 | 3,922 | -58.04% | 32,838 | 14,826 | (38,116) | 32,687 | |
| 投資收益 | 11,987 | -12.05% | 57,848 | 30,193 | 7,627 | 24,365 | |
| 其中：對聯營企業和合營企業的投資收益 | (661) | -369.85% | (2,117) | (3,018) | 1,846 | 3,074 | |
| 營業利潤 | 139,274 | -88.45% | 2,909,062 | 3,491,285 | 3,813,393 | 5,160,179 | |
| 利潤總額 | 154,317 | -87.16% | 3,729,700 | 3,349,461 | 3,723,136 | 5,152,795 | |
| 減：所得稅費用 | 36,396 | -80.17% | 448,820 | 609,033 | 542,186 | 746,553 | |
| 淨利潤 | 117,921 | -88.42% | 3,280,880 | 2,740,427 | 3,180,950 | 4,406,242 | |
| 減：非控股權益 | -- | -- | -- | -- | -- | -- | |
| 股東淨利潤 | 117,921 | -88.42% | 3,280,880 | 2,740,427 | 3,180,950 | 4,406,242 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.040 | -88.89% | 1.170 | 0.940 | 1.060 | 1.440 | |
| 每股派息 (元) * | -- | -- | 0.428 | 0.602 | 0.420 | 0.400 | |
| 每股淨資產 (元) * | 5.854 | 8.09% | 5.830 | 5.109 | 4.812 | 4.442 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 23/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
